Correlation Between Novo Nordisk and Aditxt

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Aditxt at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Aditxt into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Aditxt Inc, you can compare the effects of market volatilities on Novo Nordisk and Aditxt and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Aditxt. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Aditxt.

Diversification Opportunities for Novo Nordisk and Aditxt

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Novo and Aditxt is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Aditxt Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aditxt Inc and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Aditxt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aditxt Inc has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Aditxt go up and down completely randomly.

Pair Corralation between Novo Nordisk and Aditxt

Considering the 90-day investment horizon Novo Nordisk AS is expected to generate 0.38 times more return on investment than Aditxt. However, Novo Nordisk AS is 2.64 times less risky than Aditxt. It trades about 0.13 of its potential returns per unit of risk. Aditxt Inc is currently generating about -0.06 per unit of risk. If you would invest  12,864  in Novo Nordisk AS on February 23, 2024 and sell it today you would earn a total of  539.00  from holding Novo Nordisk AS or generate 4.19% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Novo Nordisk AS  vs.  Aditxt Inc

 Performance 
       Timeline  
Novo Nordisk AS 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Novo Nordisk AS are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Novo Nordisk may actually be approaching a critical reversion point that can send shares even higher in June 2024.
Aditxt Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aditxt Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in June 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Novo Nordisk and Aditxt Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Novo Nordisk and Aditxt

The main advantage of trading using opposite Novo Nordisk and Aditxt positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Aditxt can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aditxt will offset losses from the drop in Aditxt's long position.
The idea behind Novo Nordisk AS and Aditxt Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world